FHI vs OZK
Federated Hermes vs Bank OZK — AI-powered side-by-side comparison
FHI
Federated Hermes
69
Buy
VS
| Metric | FHI | OZK |
|---|
| AI Score |
69
|
69
|
| Price |
$63.14
|
$51.40
|
| P/E Ratio |
11.61×
|
8.47×
|
| ROE |
33.7%
|
11.7%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
71.6%
|
62.5%
|
| Debt / Equity |
0.36×
|
0.07×
|
| Dividend Yield |
2.3%
|
3.6%
|
| RSI (14) |
64.2
|
50.8
|
| Beta |
0.631
|
0.877
|
| Expected Upside |
—
|
+0.2%
|
AI Committee View
Current Innellis committee reasoning for FHI versus OZK.
The committee scores are tied.
FHI and OZK both score 69/100.
FHI Committee View
100% agreement
6 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is 4 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- P/E of 11.8 is inexpensive for the broad market — Value
- ROE of 33.9% shows genuine earnings power backing the valuation — Value
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
- Bollinger bandwidth of 16.2% signals elevated volatility — Risk
OZK Committee View
83% agreement
6 analysts
The primary driver is low leverage (debt-to-equity 0.08) -- balance sheet can absorb a shock. The main limiting factor is eps declining -1.7% yoy despite any revenue growth. The committee is constructive but not yet at full conviction.
Bull Case
- P/E of 8.4 is inexpensive for the broad market — Value
- Price-to-book of 0.9x is a discount to asset value — Value
- Dividend yield of 3.6% pays you to wait — Value
Bear Case
- EPS declining -1.7% YoY despite any revenue growth — Growth
- 4 consecutive earnings misses -- execution concerns — Growth